SBL
ITCI

Sargent Bickham Lagudis’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Sargent Bickham Lagudis’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-197
Closed -$3K – 832
2017
Q3 		$3K Hold
197
– – ﹤0.01% 746
2017
Q2 		$2K Hold
197
– – ﹤0.01% 733
2017
Q1 		$3K Hold
197
– – ﹤0.01% 688
2016
Q4 		$3K Hold
197
– – ﹤0.01% 659
2016
Q3 		$3 Hold
197
– – ﹤0.01% 669
2016
Q2 		$8K Hold
197
– – ﹤0.01% 578
2016
Q1 		$5K Buy
+197
New +$6.57K ﹤0.01% 634

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return